All Stories

  1. Pharmacotherapy for Hoarding Disorder: How did the Picture Change since its Excision from OCD?

    Article • Current Neuropharmacology, July 2019, Bentham Science Publishers

    Gabriele Sani, Dr Georgios D. Kotzalidis, MASSIMO PASQUINI

  2. Treatment of psychiatric disturbances in hypokinetic movement disorders

    Article • Expert Review of Neurotherapeutics, July 2019, Taylor & Francis

    MASSIMO PASQUINI, Giovanni Fabbrini

  3. Triggers for Atrial Fibrillation: The Role of Anxiety

    Article • Cardiology Research and Practice, February 2019, Hindawi Publishing Corporation

    Francesco Fedele, MASSIMO PASQUINI

  4. Treatment of psychiatric disturbances in common hyperkinetic movement disorders

    Article • Expert Review of Neurotherapeutics, December 2018, Taylor & Francis

    Dr Antonella Conte, MASSIMO PASQUINI, Giovanni Fabbrini

  5. Neuropsychiatric disturbances in atypical parkinsonian disorders

    Article • October 2018, Dove Medical Press

    MASSIMO PASQUINI, Prof. Maurizio Pompili, Giovanni Fabbrini

  6. Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease

    Article • January 2018, Dove Medical Press

    Prof. Maurizio Pompili, Dr Antonella Conte, MASSIMO PASQUINI, Giovanni Fabbrini, Dorian Lamis

  7. The Association of Anger with Symptom Subtypes in Severe Obsessive-Compulsive Disorder Outpatients

    Article • Psychopathology, January 2016, Karger Publishers

    MASSIMO PASQUINI

  8. Non-motor symptoms in patients with adult-onset focal dystonia: Sensory and psychiatric disturbances

    Article • Parkinsonism & Related Disorders, January 2016, Elsevier

    MASSIMO PASQUINI

  9. Clinical course of psychiatric disorders in patients with cervical dystonia

    Article • Psychiatry Research, September 2015, Elsevier

    MASSIMO PASQUINI

  10. Cognitive Behavioral Therapy in Movement Disorders: A Review

    Article • Movement Disorders Clinical Practice, June 2015, Wiley

    MASSIMO PASQUINI

  11. Fatigue Experiences Among OCD Outpatients

    Article • Psychiatric Quarterly, March 2015, Springer Science + Business Media

    MASSIMO PASQUINI

  12. CBT Group Intervention for Depression, Anxiety, and Motor Symptoms in Parkinson's Disease: Preliminary Findings

    Article • International Journal of Cognitive Therapy, March 2015, Guilford Publications

    MASSIMO PASQUINI

  13. Ethiopathogenesis of Depressive Disorders

    Article • Clinical Practice and Epidemiology in Mental Health, November 2014, Bentham Science Publishers

    MASSIMO PASQUINI

  14. Unexpected association between joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type and obsessive–compulsive personality disorder

    Article • Rheumatology International, November 2013, Springer Science + Business Media

    MASSIMO PASQUINI

  15. Psychiatric disorders in patients with essential tremor

    Article • Parkinsonism & Related Disorders, September 2012, Elsevier

    MASSIMO PASQUINI

  16. Acute psychiatric treatment and the use of physical restraint in first-generation immigrants in Italy: A prospective concurrent study

    Article • International Journal of Social Psychiatry, June 2012, SAGE Publications

    MASSIMO PASQUINI

  17. Core Depressive Symptoms In Depressed Cancer Outpatients

    Article • Clinical Practice and Epidemiology in Mental Health, December 2011, Bentham Science Publishers

    MASSIMO PASQUINI

  18. Symptomatic subsyndromal depression in hospitalized hypertensive patients

    Article • Journal of Affective Disorders, December 2011, Elsevier

    Professor Gino Iannucci, MASSIMO PASQUINI

  19. Nonmotor symptoms in adult-onset focal dystonia: Psychiatric abnormalities

    Article • Movement Disorders, March 2011, Wiley

    MASSIMO PASQUINI

  20. Psychiatric disorders in adult onset focal dystonia

    Article • Movement Disorders, March 2011, Wiley

    MASSIMO PASQUINI

  21. Usefulness of mirtazapine in cancer patients

    Article • Clinical Management Issues, September 2010, Seed SRL

    MASSIMO PASQUINI

  22. Amantadine Augmentation for Refractory Obsessive-Compulsive Disorder

    Article • Journal of Clinical Psychopharmacology, February 2010, Wolters Kluwer Health

    MASSIMO PASQUINI

  23. Psychiatric disorders in adult-onset focal dystonia: A case-control study

    Article • Movement Disorders, January 2010, Wiley

    MASSIMO PASQUINI

  24. Quetiapine for Tamoxifen-Induced Insomnia in Women With Breast Cancer

    Article • Psychosomatics, March 2009, Elsevier

    MASSIMO PASQUINI

  25. Psychopathological features of obsessive–compulsive disorder in an Italian family with Gilles de la Tourette syndrome not linked to the SLITRK1 gene

    Article • Psychiatry Research, October 2008, Elsevier

    MASSIMO PASQUINI

  26. Differences in depressive thoughts between major depressive disorder, IFN-α-induced depression, and depressive disorders among cancer patients

    Article • Journal of Psychosomatic Research, August 2008, Elsevier

    MASSIMO PASQUINI

  27. What every psychiatrist should know about PANDAS: a review

    Article • Clinical Practice and Epidemiology in Mental Health, January 2008, Bentham Science Publishers

    MASSIMO PASQUINI

  28. Memantine augmentation for refractory obsessive–compulsive disorder

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, August 2006, Elsevier

    MASSIMO PASQUINI

  29. Nicotine augmentation for refractory obsessive-compulsive disorder. A case report

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 2005, Elsevier

    MASSIMO PASQUINI

  30. Higher Levels of Anger and Aggressiveness in Major Depressive Disorder Than in Anxiety and Somatoform Disorders

    Article • The Journal of Clinical Psychiatry, March 2004, Physicians Postgraduate Press, Inc

    MASSIMO PASQUINI

  31. Association of schizophrenia and Carpenter syndrome

    Article • Acta Neuropsychiatrica, October 2003, Cambridge University Press

    MASSIMO PASQUINI

  32. Mirtazapine for Hyperhidrosis

    Article • Psychosomatics, September 2003, Elsevier

    MASSIMO PASQUINI

  33. Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System

    Article • Journal of Clinical Psychopharmacology, February 2002, Wolters Kluwer Health

    MASSIMO PASQUINI

  34. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms

    Article • Psychiatry Research, December 2001, Elsevier

    MASSIMO PASQUINI

  35. Stress, attachment and skin diseases: a case-control study

    Article • Journal of the European Academy of Dermatology and Venereology, December 1995, Wiley

    MASSIMO PASQUINI

  36. Dimensional Psychopharmacology in Somatising Patients

    Article • Karger Publishers

    MASSIMO PASQUINI